MAGDALENA MAKARUCHA: Open Payments
NPI 1952701039 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 11 payments from 9 companies in 2025. Trend: 2023 $96 · 2024 $91 · 2025 $234
Food & beverage: $162Education: $72
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 3 | $72 |
| SCPHARMACEUTICALS INC. | 1 | $30 |
| Vifor Pharma, Inc. | 1 | $25 |
| AKEBIA THERAPEUTICS INC | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: RAYALDEE, FUROSCIX, Veltassa, Vafseo, Vanrafia, JARDIANCE, TARPEYO, JYNARQUE.
Industry payments across TN — which companies pay providers there.
